Clinical
RSSArticles
-
Plazomicin Injection (Zemdri)
Plazomicin is indicated for the treatment of adults ≥ 18 years of age with complicated urinary tract infections.
-
Sepsis-related Neurologic Dysfunction Strongly Associated With Long-term Mortality
In this multicenter, retrospective study, acute neurologic dysfunction was the organ dysfunction most strongly associated with short- and long-term mortality in patients surviving a sepsis hospitalization.
-
Worse Than Snake Oil
Rattlesnake “pills” are basically dehydrated, ground up rattlesnake meat stuffed into gel caps. These may be sold locally in health food stores and are available online. The FDA has not reviewed nor approved this item.
-
Invasive Procedures and the Risk of Infective Endocarditis
This large study suggests that several invasive, nondental medical procedures may be triggers for subsequent infective endocarditis, reopening the debate regarding prevention and management.
-
Does Triple Inhaled Therapy for COPD Decrease Exacerbations Compared to Dual Therapy?
A single dose of inhaled triple therapy improved exacerbations compared to dual therapy in COPD patients.
-
Radar Is Up for Rise of Mycoplasma Genitalium
Concerns about Mycoplasma genitalium, a sexually transmitted infection, are on the rise.
-
HIV Testing: Time to Combat Missed Opportunities
Results of a recent national analysis suggest that many people who are infected with HIV but not aware of their infection were not offered HIV testing during recent clinical visits.
-
Young Men Need Sexual and Reproductive Health Services
Many young men may not be receiving the sexual and reproductive health services they need.
-
Keep Heart Health in Mind During Annual Exams
With cardiovascular disease now the leading cause of death for women, the American Heart Association and the American College of Obstetricians and Gynecologists have issued a joint advisory to help women lower their risk factors for heart disease and stroke.
-
Help Women Consider Options for Postmenopausal Vaginal Dryness
Data from a large longitudinal study indicate that more than 33% of women ages 57-69 report symptoms of vaginal dryness. However, research shows that more than 50% of women don’t report such conditions to their healthcare providers. Even fewer women take advantage of proven therapies such as vaginal estrogen tablets, creams, and rings.